1. Applicability of Routine Targeted Next-generation Sequencing to Estimate Tumor Mutational Burden (TMB) in Patients Treated With Immune Checkpoint Inhibitor Therapy. Issue 2 (February 2020) Authors: Pinato, David J.; Urus, Heather; Newsom-Davis, Thomas; Du Parcq, Persephone; Belessiotis, Katherine; Mapara, Leah; Gupta, Nandita; Power, Danielle; Weir, Justin; Wong, Ching Ngar; Ratnakumaran, Ragu P.; Dominy, Kathy; Khorashad, Jamshid; Bower, Mark Journal: Journal of immunotherapy Issue: Volume 43:Issue 2(2020:Feb./Mar.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CR2Cancer: a database for chromatin regulators in human cancer. Issue Volume 46:Issue D1(2018) (3rd October 2017) Authors: Ru, Beibei; Sun, Jianlong; Tong, Yin; Wong, Ching Ngar; Chandra, Aditi; Tang, Acacia Tsz So; Chow, Larry Ka Yue; Wun, Wai Lam; Levitskaya, Zarina; Zhang, Jiangwen Journal: Nucleic acids research Issue: Volume 46:Issue D1(2018) Page Start: D918 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Qualification of tumour mutational burden by targeted next‐generation sequencing as a biomarker in hepatocellular carcinoma. (16th November 2020) Authors: Wong, Ching Ngar; Fessas, Petros; Dominy, Kathy; Mauri, Francesco A.; Kaneko, Takahiro; Parcq, Persephone Du; Khorashad, Jamshid; Toniutto, Pierluigi; Goldin, Robert D.; Avellini, Claudio; Pinato, David J. Journal: Liver international Issue: Volume 41:Number 1(2021) Page Start: 192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗